Cargando…

Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis

AIMS: Statin liver safety in non‐alcoholic fatty liver disease (NAFLD) patients is not well defined. We analysed differences in liver function tests, including alanine transaminase aminotransferase (ALT), aspartate transaminase (AST) and gamma‐glutamyl transpeptidase (GGT) in NAFLD patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pastori, Daniele, Pani, Arianna, Di Rocco, Arianna, Menichelli, Danilo, Gazzaniga, Gianluca, Farcomeni, Alessio, D'Erasmo, Laura, Angelico, Francesco, Del Ben, Maria, Baratta, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Meta‐analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290532/ https://www.ncbi.nlm.nih.gov/pubmed/34133035 http://dx.doi.org/10.1111/bcp.14943

Ejemplares similares

Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses
por: Gazzaniga, Gianluca, et al.
Publicado: (2023)

Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2022)

Alectinib for treating patients with metastatic ALK-positive NSCLC: systematic review and network metanalysis
por: Samacá-Samacá, Daniel, et al.
Publicado: (2023)

Role of Peroral Endoscopic Myotomy in Advanced Achalasia Cardia With Sigmoid and/or Megaesophagus: A Systematic Review and Metanalysis
por: Mandavdhare, Harshal S, et al.
Publicado: (2022)

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis
por: Violi, Francesco, et al.
Publicado: (2020)

Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review
por: Coronati, Mattia, et al.
Publicado: (2022)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Donor-to-recipient gender match in liver transplantation: A systematic review and meta-analysis
por: Lai, Quirino, et al.
Publicado: (2018)

Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
por: Baratta, Francesco, et al.
Publicado: (2019)

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?
por: Baratta, Francesco, et al.
Publicado: (2015)

D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2021)

New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
por: Ferro, Domenico, et al.
Publicado: (2020)

Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis
por: Lai, Quirino, et al.
Publicado: (2018)

Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Correction to: D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis
por: Decharatanachart, Pakanat, et al.
Publicado: (2021)

Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
por: Zhu, Kai, et al.
Publicado: (2023)

HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Di Costanzo, Alessia, et al.
Publicado: (2020)

Novel glucose-lowering drugs for non-alcoholic fatty liver disease
por: Fu, Zuo-Di, et al.
Publicado: (2021)

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
por: Di Costanzo, Alessia, et al.
Publicado: (2018)

Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma
por: Yadav, Dipesh Kumar, et al.
Publicado: (2018)

Prevalence of statin intolerance: a meta-analysis( )
por: Bytyçi, Ibadete, et al.
Publicado: (2022)

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Tang, Yao, et al.
Publicado: (2019)

Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis
por: Huang, Yi-Zhou, et al.
Publicado: (2021)

Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2017)

Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
por: Pan, Lu, et al.
Publicado: (2021)

Laparoscopic versus open liver resections of posterolateral liver segments – a systematic review and meta-analysis
por: Rubinkiewicz, Mateusz, et al.
Publicado: (2020)

Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis
por: Hu, Jianping, et al.
Publicado: (2017)

Minimizing drug-drug interactions between dabigatran and levetiracetam through clinical management: a case report
por: Menichelli, Danilo, et al.
Publicado: (2023)

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management
por: Pignatelli, Pasquale, et al.
Publicado: (2020)

Statin use and endometrial cancer risk: a meta-analysis
por: Yang, Jing, et al.
Publicado: (2017)

Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2015)

Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis
por: Han, Yue, et al.
Publicado: (2016)

Outcome of split liver transplantation vs living donor liver transplantation: A systematic review and meta-analysis
por: Garzali, Ibrahim Umar, et al.
Publicado: (2023)

Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis
por: Patel, Parita, et al.
Publicado: (2020)

Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis
por: Gong, Hang, et al.
Publicado: (2021)

Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease
por: Wruck, Wasco, et al.
Publicado: (2017)

Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis
por: de Freitas Júnior, João Remí, et al.
Publicado: (2021)

Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Ma, Qianqian, et al.
Publicado: (2022)

Unraveling the Interplay between Nonalcoholic Fatty Liver Disease and Polycystic Ovary Syndrome in Adolescents: Pathogenesis, Prevalence, and Management Strategies
por: Półkośnik, Kinga, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fr727u21cunn210ncl9n6abe0g